Himmelfarb Health Sciences Library, The George Washington University

Health Sciences Research Commons
Health Policy and Management Informal
Communications

Health Policy and Management

5-10-2007

Mandating HPV vaccination--Private rights, public
good
Alexandra M. Stewart
George Washington University

Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/sphhs_policy_informal
Part of the Health Policy Commons
Recommended Citation
Stewart, A.M. (2007). Mandating HPV vaccination--private rights, public good. New England Journal of Medicine, 356(19),
1998-1999.

This Letter to the Editor is brought to you for free and open access by the Health Policy and Management at Health Sciences Research Commons. It has
been accepted for inclusion in Health Policy and Management Informal Communications by an authorized administrator of Health Sciences Research
Commons. For more information, please contact hsrc@gwu.edu.

n e w e ng l a n d j o u r na l

The

of

m e dic i n e

c or r e sp ondence

Mandating HPV Vaccination — Private Rights, Public Good
To the Editor: Those who oppose mandating
vaccination against human papillomavirus (HPV)
as a condition for school entry generally open the
debate with two fundamental questions. First,
how can the government interfere in the medical
decisions parents make for their children by
compelling immunizations for school entry? Second, how can the HPV vaccine be a good candidate for school mandates when HPV infection is
transmitted only through intimate contact, not
through casual encounters, as with other diseases that are preventable with vaccines? In fact, requiring vaccination against HPV for school entry
is firmly rooted in American jurisprudence.
The Supreme Court, when first adjudicating
compelled vaccination, recognized that the “pothis week’s letters
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lice power” granted to states under the Constitution’s 10th Amendment permits all jurisdictions
to legislate to “protect the public health and the
public safety.”1 Thus, the Court said, Massachusetts was acting within its appropriate authority
when requiring persons to submit to vaccination
against smallpox and when imposing sanctions
for noncompliance. Seventeen years later, the
Court affirmed a Texas mandate that required
documentation of the receipt of certain vaccinations before children could enter school.2
Today, all states and the District of Columbia
have instituted immunization requirements for
school entry and all jurisdictions provide a procedure for parents to opt out of the requirements.
These mandates have proved to be the most effective tool ever devised for increasing access to
recommended vaccines for our children. Indeed,
the national coverage rate for most childhood vaccines is 95%.3
Another argument against compulsory HPV
vaccination contends that because the infection
is not casually communicable, the traditional justifications outlined in previous judicial decisions do
not apply. However, the mode of transmission is
a distinction without meaningful difference, and
the result is the same. Twenty million persons
are currently infected with HPV; 6 million more
become infected each year. The threat to the
public’s health, at least with respect to vaccinerelated strains, is preventable with the vaccine.
Legal precedent, although established before
the introduction of the new vaccine against a virus that is transmitted through intimate contact,
will nevertheless serve as the nexus for decisions
about the future. If courts are ever called on to
review the appropriateness of mandating vaccination against HPV, the traditional underlying
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principles set forth to justify vaccine mandates
could easily outweigh concerns about the mode
of transmission. Courts must rely on and respect
the established precedent on which immunization mandates have been built.
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Treatment of Infertility in the Polycystic Ovary Syndrome
To the Editor: In their report on the treatment
of infertility in women with the polycystic ovary
syndrome, Legro et al. (Feb. 8 issue)1 do not mention lifestyle interventions, although a significant
proportion of the women in their study were
obese. Many studies have shown that weight reduction normalizes ovulation, improves hyperandrogenism, and ultimately increases rates of
conception among women with the polycystic
ovary syndrome.2 In fact, ovulation rates similar
to those achieved in the two recent trials with
metformin1,3 have been previously reported in
association with lifestyle interventions.4
In addition to infertility in anovulatory women,
the polycystic ovary syndrome is associated with
metabolic disorders that are linked to insulin resistance and central obesity.5 The administration
of clomiphene alone does not target these abnormalities, and in the study by Legro et al. it actually led to increases in weight and insulin resistance. In contrast, weight loss has been associated
with a significant reduction of visceral fat, leading to an improved metabolic profile.2
On the basis of this evidence, we believe that
lifestyle modifications — increased exercise, a
properly supervised diet, and smoking cessation
— should be the first and are probably the most
important steps in the therapeutic approach to
the polycystic ovary syndrome in obese women.
Dimitrios Panidis, M.D., Ph.D.
Dimitrios Farmakiotis, M.D.
Aristotle University of Thessaloniki
54006 Thessaloniki, Greece
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To the Editor: Legro et al. assert that the inferiority of metformin in achieving live births is inconsistent with the findings of previous studies,
which show the benefits of metformin in stimulating ovulation. However, in the previous studies, subjects received metformin in an immediaterelease form, whereas the subjects in the study by
Legro et al. received metformin in the extendedrelease form, which may not be as efficacious in
lowering insulin, androgen, and sex hormone–
binding globulin levels.
Clinical experience with extended-release metformin suggests that it is not as effective as the
immediate-release form for glycemic control. The
nonsignificant decreases in the levels of glucose,
insulin, proinsulin, and insulin resistance as determined by homeostasis model assessment associated with metformin in the study by Legro
and colleagues provide support for this impression. In an initial study of immediate-release
metformin, reported by Nestler and Jakubowicz,1
sex hormone–binding globulin levels increased
by 187.5% (vs. a 12.0% increase with extended-
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